Department of Dermatology and Venereology, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Dermatol Ther. 2021 May;34(3):e14950. doi: 10.1111/dth.14950. Epub 2021 Mar 31.
Coronavirus disease-2019 (COVID-19), which emerged in late 2019 and caused a pandemic, has significantly affected outpatient admissions to dermatology outpatient clinics. There have been changes in the number and composition of the patients who applied to the outpatient clinics. The dermatology outpatient clinic applications have dramatically decreased due to restrictions and prohibitions, and active participation of dermatologists in the field immediately after the pandemic. The composition of the diagnoses has also altered for reasons such as excessive use of hygiene products and types of protective equipment usage related to COVID-19. Intensive precautions have been taken in the first 3 months of the pandemic (March, April, and May). As of 12 May, controlled socialization started with new regulations. This period has been called "the normalization process." This study aims to evaluate the changes of the patients admitted to dermatology outpatient clinics within the normalization process. Despite the increasing number of COVID-19 patients and related deaths in the whole country with the new normal, the admissions to dermatology outpatient clinics have increased. During this period, acne and related diseases, pigmentation disorders, and viral skin infections had increased; dermatoses, xerosis cutis, and superficial fungal infections had reduced. It seems that nonurgent dermatological complaints affect the quality of life of patients and cause the need for an application. Although restrictions reduce these numbers, measures should be taken to protect patients and society during the ongoing pandemic.
2019 年末出现的导致大流行的 2019 冠状病毒病（COVID-19），显著影响了皮肤科门诊的就诊量。申请门诊的患者数量和构成发生了变化。由于限制和禁止措施以及皮肤科医生在大流行后立即积极参与，门诊就诊量显著减少。由于过度使用卫生产品以及与 COVID-19 相关的防护设备类型等原因，诊断构成也发生了变化。在大流行的头 3 个月（3 月、4 月和 5 月）采取了强化预防措施。截至 5 月 12 日，随着新规定的出台，开始有控制地进行社交活动。这一时期被称为“正常化过程”。本研究旨在评估在正常化过程中皮肤科门诊就诊患者的变化。尽管全国 COVID-19 患者和相关死亡人数不断增加，且新常态下的限制和禁止措施有所放宽，但皮肤科门诊就诊量仍有所增加。在此期间，痤疮和相关疾病、色素障碍以及病毒性皮肤感染有所增加；皮肤病、皮肤干燥症和浅部真菌感染有所减少。看来非紧急性皮肤病投诉影响了患者的生活质量，导致需要就诊。尽管限制措施减少了这些人数，但在大流行期间，仍应采取措施保护患者和社会。
